Barely Significant
← all excerpts

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE.

Ophthalmol Sci · 2026 · PMC13084404 · PMID 42005909

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantP < 0.05actually significant
In eyes with serous PED at baseline, faricimab resulted in a greater decrease in maximum PED thickness throughout head-to-head dosing compared with aflibercept ( Fig 1 B), with nominally significant differences (nominal P < 0.05) at weeks 4 and 12.

also in 4,806 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.